Smartleaf Asset Management
AMPH icon

Smartleaf Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Smartleaf Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.74K Sell
215
-58
-21% -$1.25K ﹤0.01% 2661
2026
Q2 		$5.65K Hold
273
– – ﹤0.01% 2636
2026
Q1 		$5.25K Buy
273
+14
+5% +$343 ﹤0.01% 2635
2025
Q4 		$6.99K Buy
259
+52
+25% +$1.34K ﹤0.01% 2552
2025
Q3 		$5.57K Buy
207
+16
+8% +$413 ﹤0.01% 2340
2025
Q2 		$4.41K Sell
191
-376
-66% -$9.33K ﹤0.01% 2092
2025
Q1 		$16.1K Sell
567
-148
-21% -$4.73K ﹤0.01% 1716
2024
Q4 		$26.3K Buy
715
+493
+222% +$22.5K ﹤0.01% 1494
2024
Q3 		$10.7K Buy
222
+122
+122% +$5.35K ﹤0.01% 1713
2024
Q2 		$4.04K Buy
+100
New +$4.14K ﹤0.01% 1900

Other funds holding AMPH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Smartleaf Asset Management's AMPH Position: Q3 2026 in Review

Smartleaf Asset Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 21% in Q3 2026, selling an estimated $1.25K and leaving 215 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #2661.

Smartleaf Asset Management first reported a position in AMPH in Q2 2024 and has held it in 10 quarters since. The position peaked at $26.3K in Q4 2024. 175 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Smartleaf Asset Management held 215 shares of Amphastar Pharmaceuticals worth $5.74K as of Q3 2026.
  • Smartleaf Asset Management sold 58 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $1.25K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2661 holding.
  • Smartleaf Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Amphastar Pharmaceuticals position peaked at $26.3K in Q4 2024.
  • 175 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.